PAX5 and acute lymphoblastic leukemia: In contrast to BCR-ABL1-negative ALL, no point mutations of PAX5 have been found, suggesting that deletions are the main mechanism of inactivation of PAX5 in BCR-ABL1-positive ALL [172].